Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Heiner Bihl"'
Autor:
Konstantin Zhernosekov, Heiner Bihl, Dimitry Filosofov, Mark Jennewein, Anatoli A. Razbash, Markus Jahn, Richard P. Baum, Frank Rösch, Peter Aschoff
Publikováno v:
Journal of Nuclear Medicine. 48:1741-1748
The (68)Ge/(68)Ga generator provides an excellent source of positron-emitting (68)Ga. However, newly available "ionic" (68)Ge/(68)Ga radionuclide generators are not necessarily optimized for the synthesis of (68)Ga-labeled radiopharmaceuticals. The e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4499d4b7e4fcac7f8ec41cbffe7f3009
https://doi.org/10.2967/jnumed.107.040378
https://doi.org/10.2967/jnumed.107.040378
Publikováno v:
Strahlentherapie und Onkologie. 177:138-144
In Hodgkin's disease accurate restaging is important to assess treatment results and may eventually provide a basis for further therapeutic strategies. A typical dilemma after treatment of Hodgkin's disease with radiographically persistent lymphoma i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ef1bf453a5d0741fe02f9f564126d8
https://doi.org/10.1007/pl00002394
https://doi.org/10.1007/pl00002394
Almost a century ago Paul Ehrlich introduced the'magic bullet'concept of targeting therapeutic agents to specific tissues in order to reduce systemic toxicity. Due to the advances in hybridoma technology in the 1980s, monoclonal antibodies (MAbs) wit
Publikováno v:
Zeitschrift für Medizinische Physik. 6:111-118
Zusammenfassung Die systemische Strahlentherapie mit radiomarkierten monoklonalen Antikorpern (Radioimmuntherapie, RIT) stellt ein vielversprechendes Konzept zur Behandlung maligner Tumoren dar. Antikorper als „carrier” fur verschiedene Radionukl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a175e966141224b5829b5b85f33193a
https://doi.org/10.1016/s0939-3889(15)70423-x
https://doi.org/10.1016/s0939-3889(15)70423-x
Autor:
Marie-Luise Sautter-Bihl, Heiner Bihl
Publikováno v:
Nuklearmedizin. 33:167-173
SummaryRadioimmunotherapy (RIT) with labeled tumor-associated monoclonal antibodies (MAbs) is a promising concept in oncology, which essentially consists of biological targeting of ionising radiation to tumors. Some encouraging clinical results have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b3ec90bdb0804b9351c03098fa7bacd
https://doi.org/10.1055/s-0038-1629812
https://doi.org/10.1055/s-0038-1629812
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 119:342-345
Monoclonal antibody (mAb) uptake in metastatic lung lesions was depicted and evaluated by digital autoradiography. The models examined were experimental metastases of a human melanoma in nude mice and spontaneous metastases of human melanoma in immun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8071144597f9a384a276644f8683a387
https://doi.org/10.1007/bf01208842
https://doi.org/10.1007/bf01208842
Publikováno v:
Nuklearmedizin. 31:137-141
ZusammenfassungDie postoperative Radiojodtherapie ist unumstrittener Bestandteil der Gesamtbehandlungsstrategie beim differenzierten Schilddrüsenkarzinom. Gelegentlich werden jedoch Jahre nach Erstdiagnose und Therapie zervikale Lymphknotenmetastase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8121c9e36c169053925eacddb83bdac7
https://doi.org/10.1055/s-0038-1629614
https://doi.org/10.1055/s-0038-1629614
Publikováno v:
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology. 17:585-596
Uptake of radiolabeled 125I monoclonal antibodies in small metastases can only be characterized by autoradiographic techniques. To obtain quantitative data out of autoradiographic images, a transformation of the essentially two-dimensional signal int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::467e02e31b6bc5649d37b50624160679
https://doi.org/10.1016/0883-2897(90)90134-m
https://doi.org/10.1016/0883-2897(90)90134-m
Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations
Autor:
Katharina Pauls, Claudia Leutner, Heiner Bihl, Reinhard Büttner, Eva Wardelmann, Nadja Thomas, Nicola Speidel, Thomas Heinicke, Sabine Merkelbach-Bruse, Peter Hohenberger
Publikováno v:
The Lancet. Oncology. 6(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b7d16bec54393ba1d34f1071096818
https://pubmed.ncbi.nlm.nih.gov/15811621
https://pubmed.ncbi.nlm.nih.gov/15811621
Autor:
Alexander Drzezga, Inga Zerr, Heiner Bihl, Jörg Spitz, Frank Grünwald, Andreas Hertel, Sigrid Poser, Henriette J. Tschampa, Karsten Henkel, Andreas Schröter, Klaus-F. Gratz, Udalrich Büll
Publikováno v:
Journal of neurology. 249(6)
The aim of this study was to explore the sites of metabolic changes with [(18)F]2-fluoro-2-desoxy-D-glucose (FDG) and positron emission tomography (PET) in patients with Creutzfeldt-Jakob disease and to correlate the findings with clinical symptoms.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8908bfdc760cadc7c135356e2e31a461
https://pubmed.ncbi.nlm.nih.gov/12111302
https://pubmed.ncbi.nlm.nih.gov/12111302